Squamous cell carcinoma of the lung: clinical criteria for treatment strategy

发表时间：2015-11-26 浏览次数：1100次

引用：

Savini A, Berardi R, Mazzanti P, Caramanti M, Santoni M, De Lisa M, Morgese F, R

关键词：

作者：

Agnese Savini, Rossana Berardi, Paola Mazzanti, Mi

作者单位：

Medical Oncology Unit, Università Politecnica dell

出版年份：

2015

期刊页数：

90-93

收录者：

其他外文数据库

摘要：

Aim: Primary lung cancer is the leading cause of human cancer deaths worldwide, and squamous cell carcinoma (SCC) is one of the most frequent histologic subtypes. The aim of our study was to analyze clinical factors potentially affecting the overall outcome of advanced lung SCC patients. Methods: A series of 72 consecutive patients with advanced SCC undergoing chemotherapy at our institution between January 2007 and July 2013 were eligible for our analysis. Results: By univariate analysis, a better overall survival (OS) was related to response to first-line chemotherapy: median OS were 19.7 vs. 7.17 months, respectively, for responders and nonresponders patients (P < 0.0001). Eastern Cooperative Oncology Group performance status, gender, and surgery were other prognostic factors. No significant relationship between OS and smoking status, age, body mass index, or type of treatment was found. In the third-line setting, a better OS was associated with objective response to second-line treatment (P = 0.015). Conclusion: Our results suggest that differences in OS seem strictly associated with clinical response to previous treatments. These data should be considered in the therapeutic strategy and management of patients with SCC of the lung.

阅读全文